Health Bulletin 8 / November /2021

Published On 2021-11-08 11:23 GMT   |   Update On 2021-11-09 06:37 GMT

Here are Top Health Stories of the day

Patient Dies Post Delivery Due to Heavy Bleeding: Consumer Court Slaps Hospital, Gynecologist, Surgeon with Rs 5 lakh compensation.

Holding the treating hospital and doctors including a gynaecologist and a surgeon guilty of medical negligence, the District Consumer Disputes Redressal Commission, Jalandhar has directed them to pay Rs 5 lakh as compensation to a complainant, whose wife died after delivery due to excessive bleeding.

Taking note of the fact that the doctors had referred the patient to another hospital when the bleeding didn't stop, the Commission noted, "OPs gave wrong treatment to deceased. If position of the wife of the complainant is not a good then why they referred the patient, wife of the complainant to another hospital. The patient died due to negligence of the OPs. OPs failed to exercise their duty with reasonable and proper care and did not take precautions guarding against injury to the patient and breach of duty which was gross negligence caused the death of the patient."

For more details, check out the full story on the link below:

Patient Dies Post Delivery Due To Heavy Bleeding: Consumer Court Slaps Hospital, Gynaecologist, Surgeon With Rs 5 Lakh Compensation


NMC tells students in advisory: Passing of first Professional exam of MBBS necessary to move to 2nd year

Passing the 1st Professional exam of MBBS is compulsory before proceeding to 2nd MBBS training, the National Medical Commission has recently clarified in its recent advisory to students. The move comes in response to the directions issued by the Andhra Pradesh High Court that had asked first-year MBBS students of Dr NTR University of Health Sciences, who did not qualify for the second year, to submit their representations to the National Medical Commission (NMC).

The students had earlier filed a petition seeking directions to the NMC and Dr NTR University of Health Sciences to give relaxation to the candidates who were unable to clear the first year exams and also permit them to attend second year classes.

For more details, check out the full story on the link below:

Kerela Medical college teachers on strike from Nov. 9


Armed Forces Medical College Pune more than doubles bond fee to Rs 61 lakh FOR MBBS ADMISSIONS 2021.

Armed Forces Medical College (AFMC) is one of the most coveted medical colleges in the country for pursuing MBBS. The AFMC Pune has released a brochure for admission to the MBBS course for the session 2021.

The brochure, the bulletin consists of eligibility criteria, required qualifications, criteria of marks, and other details about the admissions to MBBS course. A total of 150 candidates (including 05 Govt. sponsored candidates from Friendly Foreign Countries) will be selected in the year 2021, of which 145 (115 boys and 30 girls) will be selected as Medical Cadets for imparting training (including MBBS course) at the Armed Forces Medical College Pune with liability to serve in the Armed Forces Medical Services as Medical Officers. The candidates selected in addition to becoming doctors will also be commissioned as officers of the Indian Armed Forces, wherein they have to be both physically and psychologically robust to be able to undergo the rigors of life in the Armed Forces. The selected candidates need to have leadership qualities, effective communication skills and exacting physical standards, as the same are prime requisites for serving officers of the Armed Forces.

For more details, check out the full story on the link below:

MBBS Admissions At AFMC 2021: Check Out Eligibility Criteria, No Of Seats, Bond Details


Delhi High Court restrains generic pharmaceutical companies from making Novartis patented drug

 In a major relief to Novartis, the Delhi High Court has restrained various generic pharmaceutical companies from manufacturing or selling Valsartan and Sacubitril tablets, a combination to treat cardiovascular diseases, as it may amount to infringement of patent of pharma major Novartis AG.

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech, generic pharma firms making or selling Valsartan and Sacubitril.

For more details, check out the full story on the link below:

HC Restrains 4 Pharma Firms From Making, Selling Novartis Sacubitril, Valsartan Tablets

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News